Contract Service Directory

Kemwell Biopharma





Company Headquarters

511 Davis Drive
Suite 100
Morrisville, NC 27560
United States

Contract Service Directory

    Content From Kemwell Biopharma

    Related Content

    • Breaking News | Clinical Trial Materials | Collaborations & Alliances | Industry News | Preclinical Outsourcing
      Ocugen Engages Kemwell Biopharma for cGMP Manufacture of OCU200

      Ocugen Engages Kemwell Biopharma for cGMP Manufacture of OCU200

      Paves the way towards getting OCU200 in the clinic by first half of 2022.
      Contract Pharma Staff 10.06.20

    • Biologics, Proteins, Vaccines
      Will Immunotherapy Knock Out Cancer?

      Will Immunotherapy Knock Out Cancer?

      Innovative immunotherapy companies discuss with WuXi AppTec what’s next for this rapidly developing field ahead of BIO 2017.
      06.14.17

    • Breaking News | cGMP Manufacture | Clinical Trial Materials | Excipients | Facilities | Industry News
      Lubrizol Unveils $60M Expansion Plan

      Lubrizol Unveils $60M Expansion Plan

      Will invest in Particle Sciences, Vesta and other facilities in 2017
      06.07.17


    • Breaking News | Promotions & Moves
      Recipharm Makes Appointment in the UK & Ireland

    • Biosimilars
      Indian Generic Firms  Expand Biosimilar Portfolios

      Indian Generic Firms Expand Biosimilar Portfolios

      With more players entering the ring, the race to enter the promising biosimilars market is getting hotter by the day in India
      S. Harachand, Contributing Editor 05.09.17

    • The Results Are In!

      The Results Are In!

      The growing need for analytical testing and clinical trials services are driving outsourcing demand.
      Tim Wright, Editor 05.09.17


    • Breaking News | cGMP Manufacture | Formulation Development | Industry News | Solid Dosage/Creams/Ointments
      Catalent Manufactures Lexicon’s Xermelo Following Approval

      Catalent Manufactures Lexicon’s Xermelo Following Approval

      To provide commercial supply of first-in-class oral therapy from its Kansas City facility
      05.09.17

    • Drug Development | Drug Discovery | Preclinical Outsourcing
      Overcoming Preclinical Drug Development Hurdles

      Overcoming Preclinical Drug Development Hurdles

      Aidan Synnott of Charles River Laboratories discusses the latest developments in oncology research models
      Kristin Brooks, Contract Pharma 05.02.17

    • Analytical Services
      Quality Risk Management

      Quality Risk Management

      It’s not just for the big guys anymore
      Emil W. Ciurczak, DoraMaxx Consulting 04.03.17


    • APIs | Cold Chain Management | Facilities | Serialization
      Newsmakers: Bill Mitchell

      Newsmakers: Bill Mitchell

      PCI Pharma Services’ CEO talks trends
      Tim Wright, Editor 03.07.17

    • Capsules | Solid Dosage/Semi-solids

      Generic Drug Trends

      Industry faces tighter capacity, consolidation, and drug pricing uncertainty
      Edward S. Price, President, PCI 03.07.17

    • Solid Dosage/Semi-solids
      Oral Solid Dosage Outsourcing: Trends & Challenges

      Oral Solid Dosage Outsourcing: Trends & Challenges

      Despite the increasing number of biologics, oral solids remain the dominant dosage form in the pharmaceutical market.
      Tim Wright, Editor, Contract Pharma 03.07.17


    • The Good, the Bad, and the Donald

      The Good, the Bad, and the Donald

      Orphan drugs, CMO continuous manufacturing and developing world sales offer biggest revenue opportunities
      01.31.17

    • APIs | cGMP Manufacture
      Navigating the Shifting Landscape of Contract API Manufacturing

      Navigating the Shifting Landscape of Contract API Manufacturing

      What does it take for a CMO to succeed and grow in the current competitive marketplace?
      Saharsh Davuluri, Joint Managing Director, Neuland Labs 01.26.17